首页> 外文期刊>Anaerobe >Incidence of and risk factors for recurrent Clostridioides difficile infection in Japan using a claims database: A retrospective cohort study
【24h】

Incidence of and risk factors for recurrent Clostridioides difficile infection in Japan using a claims database: A retrospective cohort study

机译:使用索赔数据库在日本复发梭菌艰难梭菌感染的发生率和危险因素:回顾性队列研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This retrospective cohort study aimed to determine the incidence rates of and risk factors for recurrent Clostridioides difficile infection (rCDI) in Japan using a claims database. Inpatients of any age with >= 1 record of C. difficile infection (CDI) during the study period (January 2012-September 2016) were analyzed. We estimated the incidence rate of health care onset, health care facility associated (HO-HCFA) primary CDI and HO-HCFA rCDI for each of the first to fifth recurrences. Risk factors for the first recurrence were investigated using a univariate, and subsequently, a multivariable Cox regression model. The incidence rates (95% confidence interval [CI]) of CDI and HO-HCFA CDI were 2.43 (2.40-2.46) and 1.26 (1.24-1.28) cases per 10,000 inpatient-days, respectively. Among the 11,287 inpatients with >= 1 HO-HCFA CDI, 1424 patients had >= 1 recurrent episode (12.6% [95% CI 12.0-13.2]). The rCDI incidence rates consistently increased, with the number of recurrences ranging from 29.2 to 181.8 cases per 10,000 inpatient-days. The multivariable analysis revealed five risk factors (hazard ratio [95% CI]): age >= 65 years (vs. = 80 years, 2.110 [1.776-2.507]); cephalosporin use both before (vs. without cephalosporin; 1.241 [1.098-1.402]) and during the primary CDI (vs. without cephalosporin; 1.137 [1.011-1.279]); higher number of comorbidities (vs. = 65 years, those with a higher number (>10) of comorbidities, and those who have received cephalosporin before or during the primary CDI. (C) 2019 Merck Inc. and the Author(s). Published by Elsevier Ltd.
机译:这种回顾性的队列研究旨在使用索赔数据库确定日本复发性梭菌艰难梭菌感染(RCDI)的发病率和危险因素。分析了在研究期间(2016年1月)的C.艰难梭菌感染(CDI)的任何年龄的住院患者进行了分析(2016年1月)。我们估计了医疗保健发病,医疗保健设施相关(HO-HCFA)原发性CDI和HO-HCFA RCDI的发病率,每次至第五次复发。使用单变量和随后进行多变量的COX回归模型来研究第一次复发的危险因素。 CDI和HO-HCFA CDI的发病率(95%置信区间[CI])分别为每10,000天的2.43(2.40-2.46)和1.26(1.24-1.28)病例。在11,287名与HO-HCFA CDI中的住院患者中,1424名患者> = 1次复发集(12.6%[95%CI 12.0-13.2])。 RCDI发病率始终如一地增加,复发次数为每10,000天内的29.2至181.8例。多变量分析揭示了五种风险因素(危险比[95%CI]):年龄> = 65岁(与80年,2.110 [1.776-2.507]);头孢菌素以前使用(Vs.没有头孢菌素; 1.241 [1.098-1.402])和在原发性CDI期间(没有头孢菌素; 1.137 [1.011-1.279]);较高数量的合并症(Vs. = 65岁,具有较高数量(> 10)的合并症,以及在主要CDI之前或期间接受头孢菌素的人。(c)2019 Merck Inc.和提交人。 elsevier有限公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号